<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02360943</url>
  </required_header>
  <id_info>
    <org_study_id>1208182</org_study_id>
    <secondary_id>2013-000315-24</secondary_id>
    <nct_id>NCT02360943</nct_id>
  </id_info>
  <brief_title>Pharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or More: PEAGE</brief_title>
  <acronym>PEAGE</acronym>
  <official_title>Pharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or More: Prospective, Multicenter Cohort Study PEAGE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The treatment of the venous thromboembolic disease, including pulmonary embolism (PE), is&#xD;
      based on anticoagulants. During the last decade, all the randomized clinical trials&#xD;
      evaluating these anticoagulants have included PE patients with an average age below 60 years.&#xD;
      But in clinical pratice, approximately 50% of PE patients are older than 75 years.&#xD;
&#xD;
      So the investigators want to perform a french multicentre prospective cohort of consecutive&#xD;
      patients receiving an anticoagulant treatment for a symptomatic and confirmed PE. All the&#xD;
      validated and available anticoagulant treatments are authorized in this cohort&#xD;
      (unfractionnated and low molecular weight heparins, fondaparinux, vitamin K antagonists and&#xD;
      direct oral anticoagulants).&#xD;
&#xD;
      This cohort will provide data regarding the bleeding risk and the risk of PE recurrences and&#xD;
      regarding the pharmacokinetic (PK) and pharmacodynamic (PD) properties of these&#xD;
      anticoagulants in this older population. Using population approach modelling , the&#xD;
      investigators will pay particular attention to the sources of PK/PD variability PK / PD such&#xD;
      as genetic polymorphisms of P-glycoprotein and cytochrome P450.&#xD;
&#xD;
      Using all these data , the investigators will try to identify significant risk factors for&#xD;
      bleeding and venous thromboembolic events.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 9, 2014</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Major bleeding defined by the International Society of Thrombosis &amp; Haemostasis</measure>
    <time_frame>at 6 months</time_frame>
    <description>Bleeding causing a fall in hemoglobin level of 20 g L-1 (1.24 mmol L-1) or more, or leading to transfusion of two or more units of whole blood or red cells.,&#xD;
Symptomatic bleeding in a critical area or organ, such as intracranial, intraspinal, intraocular, retroperitoneal, intra-articular or pericardial, or intramuscular with compartment syndrome,&#xD;
Fatal bleeding</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinically relevant non-major bleeding</measure>
    <time_frame>at 6 months</time_frame>
    <description>defined by:&#xD;
Subcutaneous hematoma spontaneous over 25 cm2&#xD;
Spontaneous epistaxis for more than 5 minutes&#xD;
Spontaneous or after urinary catheter hematuria for more than 24 hours&#xD;
Significant rectal bleeding&#xD;
Gingival bleeding for more than 5 minutes&#xD;
Bleeding requiring hospitalization and / or a hemostatic action</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrent pulmonary embolism</measure>
    <time_frame>at 6 months</time_frame>
    <description>confirmed by CT scan or ventilation/perfusion lung scan</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Deep vein thrombosis (recurrence or new)</measure>
    <time_frame>at 6 months</time_frame>
    <description>confirmed by venous doppler ultrasonography or venography of the lower limbs or CT scan</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial cardiovascular events</measure>
    <time_frame>at 6 months</time_frame>
    <description>Acute coronary syndrom with or without ST-segment elevation&#xD;
Stroke ischemic or hemorrhagic confirmed by CT scan or magnetic resonance imaging brain&#xD;
Acute ischemic phenomena (lower limbs, mesenteric ...) confirmed by arterial doppler or arteriography.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death</measure>
    <time_frame>at 6 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Elderly</condition>
  <condition>Pulmonary Embolism</condition>
  <condition>Anticoagulants</condition>
  <arm_group>
    <arm_group_label>PEAGE</arm_group_label>
    <description>Patients older than 75 years receiving an anticoagulant treatment for a symptomatic and confirmed PE</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>4 blood samples</intervention_name>
    <description>PK and / or PD measurements during hospitalization</description>
    <arm_group_label>PEAGE</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients older than 75 years receiving an anticoagulant treatment (unfractionnated and low&#xD;
        molecular weight heparins, fondaparinux, vitamin K antagonists and direct oral&#xD;
        anticoagulants) for a symptomatic and confirmed pulmonary embolism&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Symptomatic pulmonary embolism confirmed by objective paraclinical examination with or&#xD;
             without DVT associated&#xD;
&#xD;
          -  confirmation of pulmonary embolism within 3 days&#xD;
&#xD;
          -  Administration possible according to the recommended dosages of anticoagulant&#xD;
             treatment : (unfractionnated and low molecular weight heparins, fondaparinux, vitamin&#xD;
             K antagonists and direct oral anticoagulants)&#xD;
&#xD;
          -  Indication of anticoagulant treatment for at least 6 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  on therapeutic dose of anticoagulant treatment over 72 hours&#xD;
&#xD;
          -  indication to therapeutic dose of anticoagulant treatment for another reason.&#xD;
&#xD;
          -  Inability for whatever reasons, to prescribe recommended anticoagulant treatment&#xD;
&#xD;
          -  PE treatment on heparin-induced thrombocytopenia requiring argatroban, lepirudin or&#xD;
             danaparoid treatment,&#xD;
&#xD;
          -  ongoing bleeding&#xD;
&#xD;
          -  PE occurring despite well conducted anticoagulant treatment&#xD;
&#xD;
          -  Contraindications to recommended dose of anticoagulant treatment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>75 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick MISMETTI, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Saint Etienne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrick MISMETTI, MD PhD</last_name>
    <phone>0477120285</phone>
    <phone_ext>+33</phone_ext>
    <email>patrick.mismetti@chu-st-etienne.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU d'Angers</name>
      <address>
        <city>Angers</city>
        <zip>49033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Marie ROY, MD PhD</last_name>
      <phone>02 41 35 37 18</phone>
      <phone_ext>+33</phone_ext>
      <email>PMRoy@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>Pierre Marie ROY, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>No√©mie LELOUP, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Caroline SOULIE-CHAVIGNON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David HUGLA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bruno CARNEIRO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David HAMDAN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antoine BRANGIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Betty MAZET, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>C√©dric ANNWEILER, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christian LAVIGNE, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guillaume DUVAL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean BARRE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie Rita ANDREU, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre-Yves PARE, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rapha√´lle HUREAUX-HUYNH, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas MOUMNEH, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ang√©lique BACHELET, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rosen CREN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emilie FRIOU, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thibault SCHOTTE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>H√©l√®ne RIVIERE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre LOZAC'H, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>H√©l√®ne MEYTADIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vincent AZZOLA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Delphine DOUILLET, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gonzague FOUCAULT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sophie DAMBRINE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>H√¥pital Universitaire Jean Minjoz</name>
      <address>
        <city>Besancon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas MENNEVEAU, MD PhD</last_name>
      <phone>03 81 66 86 24</phone>
      <phone_ext>+33</phone_ext>
      <email>nicolas.meneveau@univ-fcomte.fr</email>
    </contact>
    <investigator>
      <last_name>Nicolas MENNEVEAU, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Brest</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique MOTTIER, MD PhD</last_name>
      <phone>02 98 34 73 36</phone>
      <phone_ext>+33</phone_ext>
      <email>dominique.mottier@chu-brest.fr</email>
    </contact>
    <investigator>
      <last_name>Dominique MOTTIER, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karine LACUT, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francis COUTURAUD, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aur√©lien DELLUC, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>C√©cile TROMEUR, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gr√©goire LE GAL, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Norbert ANDRE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aude BARNIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Am√©lie BAZIRE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christophe GUT-GOBERT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nolwenn ASTRUC, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emmanuelle LE MOIGNE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laurent SIMONIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rapha√´l LE MAO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luc BRESSOLLETTE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xavier SAVARY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Baptiste HOURMANT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cl√©ment HOFFMANN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>B√©n√©dicte ROUVIERE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ga√´l PICART, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>C√©cile L'HEVEDER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique du Parc - Castelnau Le Lez</name>
      <address>
        <city>Castelnau Le Lez</city>
        <zip>34170</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique BRISOT, MD</last_name>
    </contact>
    <investigator>
      <last_name>Dominique BRISOT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aur√©lie KHAU VAN KIEN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yoann THIBOUT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Gabriel Montpied</name>
      <address>
        <city>Clermont Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>H√¥pitaux Universitaires Louis Mourier Paris Nord</name>
      <address>
        <city>Colombes</city>
        <zip>92700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle MAHE, MD PhD</last_name>
      <phone>01 47 60 64 90</phone>
      <phone_ext>+33</phone_ext>
      <email>isabelle.mahe@lmr.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Isabelle MAHE, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie-C√©cile COURTOIS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aude ROSSI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Caroline FOURGEAUD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maxime DELRUE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sylvie GUINEMER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Louis JOURNEAU, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>G√©raldine POENOU, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ludovic PLAISANCE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emmanuel TOLEDANO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas FALVO, MD</last_name>
      <phone>03 80 29 34 32</phone>
      <phone_ext>+33</phone_ext>
    </contact>
    <investigator>
      <last_name>Nicolas FALVO, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sabine BERTHIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fr√©d√©rik LEDAN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>L√©o FRECHIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gilles PERNOD, MD PhD</last_name>
      <phone>04 76 76 57 17</phone>
      <phone_ext>+33</phone_ext>
      <email>GPernod@chu-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>Gilles PERNOD, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maxime MAIGNAN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sophie BLAISE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne LEDOYEN-JANKOWSKI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Limoges</name>
      <address>
        <city>Limoges</city>
        <zip>87000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe LACROIX, MD PhD</last_name>
    </contact>
    <investigator>
      <last_name>Philippe LACROIX, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle QUERE, MD PhD</last_name>
      <phone>04.67.33.70.25</phone>
      <phone_ext>+33</phone_ext>
      <email>i-quere@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Isabelle QUERE, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aurore FANDOS BLANQUIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emilie VALDELIEVRE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Philippe GALANAUD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lorris LE COLLEN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pauline LHORTE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yacine RABAH, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierrick HENNETON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandrine MESTRE GODIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU de Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gilles BERRUT, MD PhD</last_name>
      <phone>02 40 68 66 68</phone>
      <phone_ext>+33</phone_ext>
      <email>gilles.berrut@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Gilles BERRUT, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pascal CHEVALET, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Typhaine RIAUDEL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie-H√©l√®ne FIX, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charlotte MASCART, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fanny PESLE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Nice</name>
      <address>
        <city>Nice</city>
        <zip>06002</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emile FERRARI, MD PhD</last_name>
      <phone>04.92.03.78.54</phone>
      <phone_ext>+33</phone_ext>
      <email>ferrari.e@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Emile FERRARI, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier CHICHE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Priscille BOUVIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nassim REDJIMI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benjamin SARTRE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mohamed LABBAOUI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pamela GATTO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>H√¥pital Europeen Georges Pompidou, APHP</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guy MEYER, MD PhD</last_name>
      <phone>01 56 09 34 62</phone>
      <phone_ext>+33</phone_ext>
      <email>guy.meyer@egp.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Jean PASTRE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier SANCHEZ, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benjamin PLANQUETTE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aude GIBELIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guillaume BRIEND, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guy MEYER, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jonathan MAREY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne ROCHE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>S√©bastien CLERC, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ilaine LOPEZ, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Manil BENLOUNES, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>APHP H√¥pital BROCA</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier HANON, MD PhD</last_name>
      <phone>(0)144083503</phone>
      <phone_ext>+33</phone_ext>
      <email>olivier.hanon@brc.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Olivier HANON, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cl√©mence BOULLY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Edouard CHAUSSADE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sophie CHAUVELIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Florian LABOUREE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laure CAILLARD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Lyon Sud</name>
      <address>
        <city>Pierre Benite</city>
        <zip>69310</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire GRANGE, MD</last_name>
      <phone>04.78.86.14.63</phone>
      <phone_ext>+33</phone_ext>
      <email>claire.grange@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Claire GRANGE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean Christophe LEGA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Rouen</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ygal BENHAMOU, MD</last_name>
    </contact>
    <investigator>
      <last_name>Ygal BENHAMOU, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Saint Etienne</name>
      <address>
        <city>Saint Etienne Cedex</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick MISMETTI, MD PhD</last_name>
      <phone>0477120285</phone>
      <phone_ext>+33</phone_ext>
      <email>patrick.mismetti@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Patrick MISMETTI, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laurent BERTOLETTI, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nathalie MOULIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandrine ACCASSAT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andr√©a BUCHMULLER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elodie DE MAGALHAES, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>C√©cile DUVILLARD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric DICONNE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre LAFOND, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bernard TARDY, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Strasbourg - H√¥pital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique STEPHAN, MD PhD</last_name>
    </contact>
    <investigator>
      <last_name>Dominique STEPHAN, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alix-Marie FALLER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elena-Mihaela CORDEANU, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>S√©bastien GAERTNER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Intercommunal Toulon La Seyne sur Mer</name>
      <address>
        <city>Toulon</city>
        <zip>83056</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antoine ELIAS, MD</last_name>
      <phone>04 94 14 52 35</phone>
      <phone_ext>+33</phone_ext>
      <email>antoine.elias@free.fr</email>
    </contact>
    <investigator>
      <last_name>Antoine ELIAS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie ELIAS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Colin RICHARD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana√Øs CORNE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dimitri CORNAND, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pauline MARTINEZ, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sarah REZKALLAH, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Tours</name>
      <address>
        <city>Tours</city>
        <zip>37000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denis ANGOULVANT, MD PhD</last_name>
    </contact>
    <investigator>
      <last_name>Denis ANGOULVANT, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fabrice IVANES, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thibaud GENET, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christophe SAINT-ETIENNE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>February 6, 2015</study_first_submitted>
  <study_first_submitted_qc>February 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2015</study_first_posted>
  <last_update_submitted>April 12, 2021</last_update_submitted>
  <last_update_submitted_qc>April 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>elderly patients</keyword>
  <keyword>Pulmonary embolism</keyword>
  <keyword>Anticoagulant treatments</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Embolism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

